Altered expression of isoforms of myosin heavy chain mRNA in the failing rat heart is ameliorated by chronic treatment with an endothelin receptor antagonist

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 1, 1998, Pages

  Sakai, Satoshi ^a   Miyauchi, Takashi ^a   Kobayashi, Tsutomu ^a   Yamaguchi, Iwao ^a   Goto, Katsutoshi ^a   Sugishita, Yasuro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Endothelin antagonist; Endothelin 1; Heart failure; Myosin heavy chain isoform; Rat

Indexed keywords

CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN RECEPTOR; MESSENGER RNA; MYOSIN; MYOSIN HEAVY CHAIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HEART; HEART MUSCLE; MALE; POLYMERASE CHAIN REACTION; RAT;

ANIMALS; CHRONIC DISEASE; HEART; HEART FAILURE, CONGESTIVE; MALE; MYOCARDIUM; MYOSIN HEAVY CHAINS; MYOSINS; PEPTIDES, CYCLIC; POLYMERASE CHAIN REACTION; RATS; RECEPTORS, ENDOTHELIN; RNA, MESSENGER;

EID: 0031629183     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800001-00084     Document Type: Article

References (18)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Suzuki T, Kumazaki T, Mitsui Y. Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 1993;193:823-30.
3. Shubeita HE, McDonough PM, Harris AN, et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. J Biol Chem 1990;265:20555-62.
4. Ito H, Hirata Y, Hiroe M, et al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 1991;69:209-15.
5. Stawski G, Olsen UB, Grande P. Cytotoxic effect of endothelin-1 during "simulated" ischemia in cultured rat myocytes. Eur J Pharmacol 1991;201:123-4.
6. Prasad MR. Endothelin stimulates degradation of phospholipids in isolated rat hearts. Biochem Biophys Res Commun 1991;174: 952-7.
7. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol 1988;255:H970-3.
8. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T. Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflugers Arch 1988;413:108-10.
9. Sakai S, Miyauchi T, Sakurai T, et al. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure; marked increase in endothelin-1 production in the failing heart. Circulation 1996;93:1214-22.
10. A receptor. Life Sci 1992;50:247-55.
11. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353-5.
12. Michel J, Lattion A, Salzmann J, et al. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1988;62:641-50.
13. Schwarts K, Chassagne C, Boheler KR. The molecular biology of heart failure [Abstract]. J Am Coll Cardiol 1993;4(suppl A):30A-3.
14. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979;44:503-12.
15. Sakai S, Miyauchi T, Sakurai T, et al. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats. J Am Coll Cardiol 1996;28:1580-8.
16. Miyauchi T, Yorikane R, Sakai S, et al. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 1993;73:887-97.
17. Kaddoura S, Firth JD, Boheler KR, Sugden PH, Poole-Wilson PA. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Circulation 1996;93:2068-79.
18. Katz AM. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 1986;73:III-184-8.